Potential Bellwether Trial Schedule Set Forth in Xarelto MDL

A June 2015 status conference revealed that bellwether trials may soon take place for the hundreds of cases consolidated in a Louisiana District Court in the Xarelto multi-district litigation (“MDL”). An MDL is a tool that courts use to consolidate cases alleging similar claims for purposes of expediting pretrial proceedings. In the Xarelto MDL, these claims all stemmed from allegations that the manufacturers of the blood thinning drug, Bayer and Janssen Pharmaceuticals, misrepresented Xarelto as being superior to warfarin despite its fatal bleeding side-effects. Possible schedules of four of the bellwether trials chosen from a pool of 50 cases are tentatively scheduled to convene in Louisiana, Texas, and Mississippi courts throughout August, September and October 2016.

Real Time Analytics